[Familial hyperkalemic hypertension - a case report with patients in three generations]

Mikael Oscarson1, Lisa Juntti-Berggren2

  • 1överläkare, med dr, ME endokrinolog, Centrum för medfödda metabola sjukdomar, Karolinska -universitets-sjukhuset Solna.

Lakartidningen
|August 6, 2025
PubMed

Insights

Genetic testing identified a KLHL3 gene variant causing familial hyperkalemic hypertension in four patients. Hydrochlorothiazide treatment normalized potassium and improved blood pressure, highlighting the value of genetic insights for personalized medicine.

Area of Science:

  • Genetics
  • Nephrology
  • Internal Medicine

Background:

  • Advancements in sequencing technologies facilitate the identification of monogenic diseases.
  • Precision medicine offers tailored therapies for various conditions.
  • Hyperkalemia of unclear origin can present diagnostic challenges.

Purpose of the Study:

  • To present a case series of four patients across three generations diagnosed with hyperkalemia.
  • To investigate the genetic basis of familial hyperkalemic hypertension in this cohort.
  • To evaluate the efficacy of hydrochlorothiazide treatment for this condition.

Main Methods:

  • Detailed family history collection.
  • Genetic testing to identify pathogenic variants.
  • Clinical assessment and monitoring of potassium levels and blood pressure.

Main Results:

  • A pathogenic variant in the KLHL3 gene was identified, confirming familial hyperkalemic hypertension.
  • Hydrochlorothiazide treatment normalized serum potassium levels in all affected patients.
  • Significant improvement in blood pressure was observed, particularly in a patient with long-standing resistant hypertension.

Conclusions:

  • Genetic testing combined with family history is crucial for diagnosing rare genetic disorders like familial hyperkalemic hypertension.
  • Targeted therapy, such as hydrochlorothiazide, can effectively manage hyperkalemia and hypertension in KLHL3-related disorders.
  • This case highlights the success of precision medicine in treating genetically defined conditions.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
769
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
68
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
75